Norstella’s Post

It is a great pleasure to share that Gianfranco Parlato, Head of Global Pricing Excellence at Servier Pharmaceuticals will be joining our panel of expert speakers at the 12th Life Sciences Pricing Forum. During his session, some of the key topics that will be covered are: ✔️ What is inflation and why does it occur? ✔️ How inflation impacts the Pharmaceutical sector and how is the industry reacting ✔️ Can pricing be a lever to counteract inflationary pressure? Different scenarios: regulated vs nonregulated products Join this premier event taking place on October 17 – 19 in Geneva to learn and network with the pricing experts in the Pharmaceutical, MedTech and Biotech industries. Download the brochure to see the full agenda and speaker line-up: https://lnkd.in/eFd8MZ5s #epp #EPPLSPF #lifesciences #pricing #pharma #medtech #biotech #pharmaceuticalindustry #pharmapricing #pricingoptimisation #marketaccess #commercialexcellence #machinelearning

Demand for outsourced services in the pharmaceutical sector is skyrocketing, with more and more companies leveraging the expertise and experience of CDMOs to enhance drug development, manufacturing, and analytical testing.   Let’s take a closer look at the trends behind this significant market growth, and some of the key considerations you should keep in mind when searching for a CDMO partner that can help you accelerate and elevate your drug development and manufacturing. https://lnkd.in/giDHZc63 #CDMO #Biotech #Pharma #Trends

CDMOs are vital partners in drug discovery and development. They offer pharmaceutical and biotech companies a range of services that streamline the process and cut costs. Here's a summary of their contributions: ➡️ Speeding Up Development: CDMOs have the facilities and expertise to handle tasks like formulation development and analytical testing, allowing drug companies to focus on discovery and pre-clinical research. ➡️ Cost-Effectiveness: Building and maintaining in-house manufacturing facilities is expensive. By outsourcing to CDMOs, companies can avoid these upfront costs. ➡️ Regulatory Compliance: CDMOs are well-versed in regulatory requirements and ensure drugs meet safety and efficacy standards. In short, CDMOs are a key part of the modern drug development ecosystem, helping bring new therapies to patients faster and at a lower cost. #renejixpharma #CDMO #clinicalresearch #drugdiscovery

#CRDMOs, or contract research, development, and manufacturing organizations, are an emerging trend to watch. These integrated, end-to-end vendors combine #CRO and #CDMO capabilities, and offer five specific benefits to #biotechnology and #pharmaceutical companies. Our new blog explores the rise of CRDMOs in depth and expands on their industry impact. Read the blog: http://spr.ly/6043X3Ow9

#CRDMOs, or contract research, development, and manufacturing organizations, are an emerging trend to watch. These integrated, end-to-end vendors combine #CRO and #CDMO capabilities, and offer five specific benefits to #biotechnology and #pharmaceutical companies. Our new blog explores the rise of CRDMOs in depth and expands on their industry impact. Read the blog: http://spr.ly/6049X3ORv

Did you know that 𝗯𝗶𝗼𝘀𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 techniques, despite their proven effectiveness in large pharmaceutical companies, are still underutilized in critical decision-making processes during drug development? This gap leads to high failure rates from target identification to clinical trials. But here's the game-changer: by embracing biosimulation, organizations can potentially slash these failure rates in half at the target identification stage alone! Imagine the impact: achieving significant time and cost savings, potentially cutting years and millions of dollars out of the process. Moreover, biosimulation isn't solely about savings—it's about the delivery of better medicines to patients, faster. Learn how biosimulation is reshaping drug development practices in our on-demand Nasdaq webinar. https://ow.ly/2Huk50RjSb8 #Biosimulation #DrugDevelopment #Webinar #PharmaceuticalIndustry #Innovation #ROI

At Amgen, alliance managers are an important part of product teams. Attendees of the 2023 #ASAPBioPharma Conference learned this and more about the company's alliance management function. https://lnkd.in/gNs2J_m3 #alliancemanagement #alliances #strategicalliances #alliancemanagers #collaboration #strategicpartnerships #pharmaceutical #pharmaceuticalindustry #biopharma #biotech #biotechnology #biotechindustry #changemanagement 

Typically, today’s drug developers collaborate with #CROs, #CMOs, and #CDMOs to help meet their research, development, and manufacturing needs. However, many #biotechnology and #pharmaceutical companies would prefer a more streamlined approach to outsourcing these activities, rather than dividing them up between different third-party vendors. Enter, the CRDMO: http://spr.ly/6049PtfuJ

Typically, today’s drug developers collaborate with #CROs, #CMOs, and #CDMOs to help meet their research, development, and manufacturing needs. However, many #biotechnology and #pharmaceutical companies would prefer a more streamlined approach to outsourcing these activities, rather than dividing them up between different third-party vendors. Enter, the CRDMO: http://spr.ly/6046PtfOo

Coriolis Pharma's Road to Success webinar: Mapping drug product development from preclinical to commercialization. Wednesday, February 21st - 16:00 (CET) / 10:00 (ET). Introducing our first speaker - Bruce Kerwin, Scientific Advisor at Coriolis Pharma, together with other leading scientific experts from Coriolis have assembled a high-level drug product development and manufacturing roadmap. The roadmap is applicable across the different modalities providing a unified framework from early phase development to commercialization of biologics drug products. This is an excellent opportunity to learn valuable insights for a successful transition from early development to market approval from the industry leader. Register here: https://lnkd.in/eBk-wmUg #CoriolisPharma #DrugProductDevelopment #PreClinical #Commercialization #PharmaDmand